Free Trial

Rep. Rick Larsen Sells Off Shares of Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Representative Rick Larsen sold between $1,001 and $15,000 in shares of Colgate-Palmolive (NYSE:CL) from his IRA account on October 6th, as disclosed in a filing on October 16th.
  • Colgate-Palmolive recently announced a quarterly dividend of $0.52 per share, with a dividend yield of 2.6%, set to be paid on November 14th.
  • After its latest earnings report, Colgate-Palmolive's stock has an average target price of $92.21, with eight analysts rating it as a "buy."
  • Five stocks we like better than Colgate-Palmolive.

Representative Rick Larsen (D-Washington) recently sold shares of Colgate-Palmolive Company NYSE: CL. In a filing disclosed on October 16th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on October 6th. The trade occurred in the Representative's "RICHARD R LARSEN IRA" account.

Representative Rick Larsen also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Zoetis NYSE: ZTS on 10/6/2025.
  • Purchased $1,001 - $15,000 in shares of Walmart NYSE: WMT on 10/6/2025.
  • Purchased $1,001 - $15,000 in shares of American Electric Power NASDAQ: AEP on 10/6/2025.
  • Sold $1,001 - $15,000 in shares of Old Dominion Freight Line NASDAQ: ODFL on 10/6/2025.
  • Purchased $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 10/6/2025.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $79.14 on Friday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The stock's fifty day moving average is $81.96 and its two-hundred day moving average is $87.39. Colgate-Palmolive Company has a 52 week low of $76.68 and a 52 week high of $100.54. The company has a market capitalization of $63.96 billion, a PE ratio of 22.23, a price-to-earnings-growth ratio of 4.58 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $0.91 earnings per share. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. Colgate-Palmolive's payout ratio is presently 58.43%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Personal CFO Solutions LLC acquired a new stake in Colgate-Palmolive in the first quarter valued at approximately $285,000. Vision Capital Management Inc. purchased a new stake in shares of Colgate-Palmolive during the 1st quarter valued at $322,000. Autumn Glory Partners LLC boosted its position in shares of Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after purchasing an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. purchased a new position in Colgate-Palmolive during the 1st quarter worth $2,166,000. Finally, Penserra Capital Management LLC raised its stake in Colgate-Palmolive by 398.6% in the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock valued at $997,000 after buying an additional 8,515 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on CL. Citigroup lowered their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Morgan Stanley decreased their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Weiss Ratings reissued a "hold (c)" rating on shares of Colgate-Palmolive in a research note on Wednesday, October 8th. UBS Group reduced their price objective on Colgate-Palmolive from $99.00 to $92.00 and set a "buy" rating on the stock in a report on Wednesday, October 8th. Finally, Barclays lowered their target price on Colgate-Palmolive from $87.00 to $82.00 and set an "equal weight" rating for the company in a report on Wednesday, October 1st. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $92.21.

Read Our Latest Stock Analysis on CL

About Representative Larsen

Rick Larsen (Democratic Party) is a member of the U.S. House, representing Washington's 2nd Congressional District. He assumed office on January 3, 2001. His current term ends on January 3, 2027. Larsen (Democratic Party) is running for re-election to the U.S. House to represent Washington's 2nd Congressional District. He declared candidacy for the 2026 election. Since at least 2011, Larsen has been assigned to the Committee on Armed Services and the Committee on Transportation and Infrastructure. Larsen's first position as an elected official was in 1998 as a member of the Snohomish County Council. Larsen earned his bachelor's degree from Pacific Lutheran University. After earning his master's degree in public affairs from the University of Minnesota, Larsen worked as the director of public affairs for the Washington State Dental Association and then as an economic development official with the Port of Everett. He went on to serve on the Snohomish County Council before seeking election to the U.S. House.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.